FDA Adverse Event Injury Summary report: N

UNKNOWN MECHANICAL HEART VALVE

MDR report key: 14804421 · Received June 24, 2022

Report

Report Number
2135147-2022-00426
Event Type
Injury
Date Received
June 24, 2022
Report Date
June 24, 2022
Manufacturer
ABBOTT MEDICAL
Product Code
LWQ
PMA / PMN Number
P810002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

AN EVENT OF THROMBUS ON A MECHANICAL VALVE LEAFLET WHICH WAS RESTRICTING THE LEAFLETS MOTION WAS REPORTED THROUGH A RESEARCH ARTICLE. A MORE COMPREHENSIVE ASSESSMENT COULD NOT BE PERFORMED AS THE EVENT WAS NON-CONTEMPORANEOUSLY REPORTED THROUGH A LITERATURE REVIEW AND NO DEVICE OR ADDITIONAL PATIENT INFORMATION WAS RECEIVED FOR ANALYSIS. BASED ON THE AVAILABLE INFORMATION, THE ROOT CAUSE OF THE REPORTED EVENT OF COULD NOT BE CONCLUSIVELY DETERMINED. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH REGARDS TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 0

AN ARTICLE FROM THE JAPANESE SOCIETY OF INTENSIVE CARE MEDICINE WAS REVIEWED. THE RESEARCH ARTICLE PRESENTS A CASE OF A ONE YEAR AND 3 MONTH OLD MALE INFANT WITH A HISTORY OF PERSISTENT TRUNCUS ARTERIOSUS. A 17MM SJM MECHANICAL HEART VALVE WAS IMPLANTED ON TRUNCAL VALVE. AFTER THE SURGERY, CARDIAC CATHETER TEST HAPPENED TO DETECT IMMOBILE ONE LEAFLET BY CHANCE. IT WAS CONSIDERED THAT THROMBI ADHERED ON THE LEAFLET. THE PATIENT WAS STARTED TO BE ADMINISTERED T-PA 0.03MG/KG/HR AND HEPARIN 20U/KG/HR. THE LEAFLET MOTION BECAME IMPROVED FOR 4-DAYS TREATMENT. NO ADDITIONAL INFORMATION WAS AVAILABLE. [ THE AUTHOR AND CORRESPONDING AUTHOR OF THIS ARTICLE IS HAYASHI, KEN, MD, KOBE CITY MEDICAL CENTER GENERAL HOSPITAL JAPAN, ¿650-0047 HYOGO, KOBE, CHUO WARD, MINATOJIMA MINAMIMACHI, 2 CHOME-1-1 TEL: +011(081)783024321 ]

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
770731 UNKNOWN MECHANICAL HEART VALVE HEART-VALVE, MECHANICAL LWQ ABBOTT MEDICAL

Patients

Seq Age Sex Outcome Treatment
1 15 MO Male Required Intervention